EDGAR Filing Documents for 0001213900-23-017841

Form 8-K - Current report:

SEC Accession No. 0001213900-23-017841

Filing Date

2023-03-06

Accepted

2023-03-06 17:02:27

Documents

Period of Report

2023-03-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea174702-8k_unicycive.htm iXBRL	8-K	60678
2	CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF THE SERIES	ea174702ex3-1_unicycive.htm	EX-3.1	139709
3	FORM OF SPECIMEN STOCK CERTIFICATE FOR SERIES A-1 PREFERRED STOCK	ea174702ex4-1_unicycive.htm	EX-4.1	513
4	FORM OF TRANCHE A WARRANT	ea174702ex4-2_unicycive.htm	EX-4.2	67783
5	FORM OF TRANCHE B WARRANT	ea174702ex4-3_unicycive.htm	EX-4.3	62748
6	FORM OF TRANCHE C WARRANT	ea174702ex4-4_unicycive.htm	EX-4.4	64710
7	FORM OF SECURITIES PURCHASE AGREEMENT, DATED MARCH 3, 2023, BY AND BETWEEN UNICY	ea174702ex10-1_unicycive.htm	EX-10.1	488788
8	PLACEMENT AGENCY AGREEMENT, DATED MARCH 3, 2023 BY AND BETWEEN UNICYCIVE THERAPE	ea174702ex10-2_unicycive.htm	EX-10.2	44000
9	PRESS RELEASE DATED MARCH 6, 2023	ea174702ex99-1_unicycive.htm	EX-99.1	21378
10	GRAPHIC	ex4-1_001.jpg	GRAPHIC	276082
11	GRAPHIC	ex10-2_001.jpg	GRAPHIC	5023
12	GRAPHIC	ex99-1_001.jpg	GRAPHIC	5056
	Complete submission text file	0001213900-23-017841.txt		1726427

Data Files

Seq	Description	Document	Type	Size
13	XBRL SCHEMA FILE	uncy-20230303.xsd	EX-101.SCH	3230
14	XBRL LABEL FILE	uncy-20230303_lab.xml	EX-101.LAB	34240
15	XBRL PRESENTATION FILE	uncy-20230303_pre.xml	EX-101.PRE	22361
17	EXTRACTED XBRL INSTANCE DOCUMENT	ea174702-8k_unicycive_htm.xml	XML	3805

Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022

Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642

Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)